Limited Use Issuer Free Writing Prospectus Sample Clauses

Limited Use Issuer Free Writing Prospectus. “Limited Use Issuer Free Writing Prospectus” includes the following: None SCHEDULE II Underwriters Principal Amount of Securities to be Purchased BofA Securities, Inc. US $ 165,000,000 TD Securities (USA) LLC $ 165,000,000 Xxxxx Fargo Securities, LLC $ 165,000,000 Citigroup Global Markets Inc. $ 67,834,000 Xxxxxxx Xxxxx & Co. LLC $ 67,834,000 X.X. Xxxxxx Securities LLC $ 67,833,000 Xxxxxx Xxxxxxx & Co. LLC $ 67,833,000 RBC Capital Markets, LLC $ 67,833,000 Scotia Capital (USA) Inc. $ 67,833,000 Barclays Capital Inc. $ 33,000,000 CIBC World Markets Corp. $ 33,000,000 Credit Suisse Securities (USA) LLC $ 33,000,000 MUFG Securities Americas Inc. $ 33,000,000 PNC Capital Markets LLC $ 22,000,000 Truist Securities, Inc. $ 22,000,000 U.S. Bancorp Investments, Inc. $ 22,000,000 Total US $ 1,100,000,000 SCHEDULE III Registration No. 333-241031 March 27, 2023 Pioneer Natural Resources Company Pricing Term Sheet Issuer: Pioneer Natural Resources Company Security Type: Senior Unsecured Offering Format: SEC Registered Expected Ratings*: Baa1/BBB/BBB+ (Stable/Stable/Stable) Trade Date: March 27, 2023 Settlement Date: March 29, 2023 (T+2) Title of Securities: Senior Notes due 2026 Principal Amount: $1,100,000,000 Stated Maturity Date: March 29, 2026 US Treasury Benchmark: 4.625% due March 15, 2026 US Treasury Yield: 3.798% Spread to US Treasury: 1.320% Yield to Maturity: 5.118% Issue Price: 99.951% of face amount Coupon: 5.100% Interest Payment Dates: March 29 and September 29 commencing September 29, 2023 Optional Redemption: Greater of par or T + 20 bps CUSIP/ISIN: 723787 AV9 / US723787AV90 Joint Book-Running Managers: BofA Securities, Inc. TD Securities (USA) LLC Xxxxx Fargo Securities, LLC Citigroup Global Markets Inc. Xxxxxxx Xxxxx & Co. LLC X.X. Xxxxxx Securities LLC Xxxxxx Xxxxxxx & Co. LLC RBC Capital Markets, LLC Scotia Capital (USA) Inc. Senior Co-Managers: Barclays Capital Inc. CIBC World Markets Corp. Credit Suisse Securities (USA) LLC MUFG Securities Americas Inc. Co-Managers: PNC Capital Markets LLC Truist Securities, Inc. U.S. Bancorp Investments, Inc. * Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time. The Issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the Issuer has filed with the...
AutoNDA by SimpleDocs
Limited Use Issuer Free Writing Prospectus. “Limited Use Issuer Free Writing Prospectus” includes the following: None SCHEDULE II Underwriters Number of Shares Credit Suisse Securities (USA) LLC 1,575,000 X.X. Xxxxxx Securities LLC 1,575,000 Deutsche Bank Securities Inc. 787,500 Xxxxxx Xxxxxxx & Co. LLC 787,500 BMO Capital Markets Corp. 58,334 Citigroup Global Markets Inc. 58,333 Xxxxxxx, Sachs & Co. 58,333 Xxxxxxx Xxxx & Company L.L.C. 58,333 Xxxxxxx Lynch, Pierce, Xxxxxx & Xxxxx Incorporated 58,334 Mitsubishi UFJ Securities (USA), Inc. 58,334 Xxxxxxx Xxxxx & Associates, Inc. 58,333 Xxxxx Xxxxxxx & Co. 58,333 UBS Securities LLC 58,333 Total 5,250,000 ANNEX I OPINION OF XXXXXX & XXXXXX L.L.P.
Limited Use Issuer Free Writing Prospectus. “Limited Use Issuer Free Writing Prospectus” includes the following: None SCHEDULE II Selling Stockholders Number of Shares to be Sold Double Eagle Energy Holdings III LLC 3,848,007 Q-FPP (VII) Subsidiary, LLC 2,151,993 Total: 6,000,000 SCHEDULE III Underwriters Number of Shares to be Purchased Xxxxxxx Sachs & Co. LLC 3,000,000 X.X. Xxxxxx Securities LLC 3,000,000 Total: 6,000,000 ANNEX I OPINION OF XXXXXX & XXXXXX LLP COUNSEL TO THE COMPANY ANNEX II OPINION OF XXXXXX & XXXXXX L.L.P. COUNSEL TO THE SELLING STOCKHOLDERS ANNEX III OPINION OF GENERAL COUNSEL TO THE COMPANY ANNEX IV FORM OF ENGINEERS’ RESERVE REPORT LETTER APPENDIX 1 to ANNEX IV AUDIT LETTER ANNEX V
Limited Use Issuer Free Writing Prospectus. The electronic roadshow available at xxx.xxxxxxxxxxx.xxx SCHEDULE II Underwriters Number of Firm Shares Xxxxxxx Lynch, Pierce, Xxxxxx & Xxxxx Incorporated 2,280,000 X.X. Xxxxxx Securities LLC 2,280,000 Total 4,560,000 ANNEX I OPINION OF XXXXXX & XXXXXX L.L.P. COUNSEL TO THE COMPANY
Limited Use Issuer Free Writing Prospectus. “Limited Use Issuer Free Writing Prospectus” includes the following: The electronic roadshow available at xxx.xxxxxxxxxxx.xxx SCHEDULE II Underwriters Number of Firm Shares Xxxxxxx Lynch, Pierce, Xxxxxx & Xxxxx Incorporated 2,750,000 X.X. Xxxxxx Securities LLC 2,750,000 Total 5,550,000 SCHEDULE III None ANNEX I OPINION OF XXXXXX & XXXXXX L.L.P.
Limited Use Issuer Free Writing Prospectus. “Limited Use Issuer Free Writing Prospectus” includes the following: The electronic roadshow available at xxx.xxxxxxxxxxx.xxx SCHEDULE II Underwriters Number of Firm Shares Citigroup Global Markets Inc. 2,655,000 Xxxxxxx, Xxxxx & Co. 1,251,000 X.X. Xxxxxx Securities LLC 1,251,000 RBC Capital Markets, LLC 1,251,000 Xxxxxxx Lynch, Pierce, Xxxxxx & Xxxxx Incorporated 216,000 Xxxxxx X. Xxxxx & Co. Incorporated 216,000 FBR Capital Markets & Co. 216,000 Xxxxxxx Xxxx & Company L.L.C. 216,000 KeyBanc Capital Markets Inc. 216,000 Xxxxxxx Xxxxx & Associates, Inc. 216,000 Scotia Capital (USA) Inc. 216,000 Xxxxxxx & Company International 216,000 Xxxxxxxx Inc. 216,000 Tudor, Pickering, Xxxx & Co. Securities, Inc. 216,000 UBS Securities LLC 216,000 Xxxxx Fargo Securities, LLC 216,000 Total 9,000,000 ANNEX I OPINION OF XXXXXX & XXXXXX L.L.P.

Related to Limited Use Issuer Free Writing Prospectus

  • Issuer Free Writing Prospectus Other than the Registration Statement, the Preliminary Prospectus and the Prospectus, the Company (including its agents and representatives, other than the Underwriters in their capacity as such) has not prepared, used, authorized, approved or referred to and will not prepare, use, authorize, approve or refer to any “written communication” (as defined in Rule 405 under the Securities Act) that constitutes an offer to sell or solicitation of an offer to buy the Shares (each such communication by the Company or its agents and representatives (other than a communication referred to in clause (i) below) an “Issuer Free Writing Prospectus”) other than (i) any document not constituting a prospectus pursuant to Section 2(a)(10)(a) of the Securities Act or Rule 134 under the Securities Act or (ii) the documents listed on Annex B hereto, each electronic road show and any other written communications approved in writing in advance by the Representatives. Each such Issuer Free Writing Prospectus complied in all material respects with the Securities Act, has been or will be (within the time period specified in Rule 433) filed in accordance with the Securities Act (to the extent required thereby) and, when taken together with the Preliminary Prospectus accompanying, or delivered prior to delivery of, such Issuer Free Writing Prospectus, did not, and as of the Closing Date and as of the Additional Closing Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided that the Company makes no representation and warranty with respect to any statements or omissions made in each such Issuer Free Writing Prospectus or Preliminary Prospectus in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in such Issuer Free Writing Prospectus or Preliminary Prospectus, it being understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in Section 7(b) hereof.

  • Issuer Free Writing Prospectuses The Company agrees that, unless it obtains the prior written consent of the Representatives, it will not make any offer relating to the Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a “free writing prospectus,” or a portion thereof, required to be filed by the Company with the Commission or retained by the Company under Rule 433; provided that the Representatives will be deemed to have consented to the Issuer Free Writing Prospectuses listed on Schedule B-2 hereto and any “road show that is a written communication” within the meaning of Rule 433(d)(8)(i) that has been reviewed by the Representatives. The Company represents that it has treated or agrees that it will treat each such free writing prospectus consented to, or deemed consented to, by the Representatives as an “issuer free writing prospectus,” as defined in Rule 433, and that it has complied and will comply with the applicable requirements of Rule 433 with respect thereto, including timely filing with the Commission where required, legending and record keeping. If at any time following issuance of an Issuer Free Writing Prospectus there occurred or occurs an event or development as a result of which such Issuer Free Writing Prospectus conflicted or would conflict with the information contained in the Registration Statement, any preliminary prospectus or the Prospectus or included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances existing at that subsequent time, not misleading, the Company will promptly notify the Representatives and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement or omission.

  • Use of Free Writing Prospectus Neither the Company nor the Agent has prepared, used, referred to or distributed, or will prepare, use, refer to or distribute, without the other party’s prior written consent, any “written communication” that constitutes a “free writing prospectus” as such terms are defined in Rule 405 under the Securities Act with respect to the offering contemplated by this Agreement (any such free writing prospectus being referred to herein as a “Free Writing Prospectus”).

  • Free Writing Prospectus The Company agrees that it will not make any offer relating to the Public Securities that would constitute an issuer free writing prospectus, as defined in Rule 433 under the Act, or that would otherwise constitute a “free writing prospectus” as defined in Rule 405.

  • Permitted Free Writing Prospectus The Company represents and warrants that it has treated and agrees that it will treat each Permitted Free Writing Prospectus as an issuer free writing prospectus, and that it has complied and will comply with the requirements of Rule 433 applicable to any Permitted Free Writing Prospectus, including timely filing with the Commission where required, legending and record keeping.

  • Free Writing Prospectuses The Company agrees that, unless it obtains the prior written consent of the Representative, it shall not make any offer relating to the Public Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a “free writing prospectus,” or a portion thereof, required to be filed by the Company with the Commission or retained by the Company under Rule 433; provided that the Representative shall be deemed to have consented to each Issuer General Use Free Writing Prospectus hereto and any “road show that is a written communication” within the meaning of Rule 433(d)(8)(i) that has been reviewed by the Representative. The Company represents that it has treated or agrees that it will treat each such free writing prospectus consented to, or deemed consented to, by the Underwriters as an “issuer free writing prospectus,” as defined in Rule 433, and that it has complied and will comply with the applicable requirements of Rule 433 with respect thereto, including timely filing with the Commission where required, legending and record keeping. If at any time following issuance of an Issuer Free Writing Prospectus there occurred or occurs an event or development as a result of which such Issuer Free Writing Prospectus conflicted or would conflict with the information contained in the Registration Statement or included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances existing at that subsequent time, not misleading, the Company will promptly notify the Underwriters and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement or omission.

  • Permitted Free Writing Prospectuses The Company represents, warrants and agrees that, unless it obtains the prior written consent of the Agent, and the Agent represents, warrants and agrees that, unless it obtains the prior written consent of the Company, it has not made and will not make any offer relating to the Placement Shares that would constitute an Issuer Free Writing Prospectus, or that would otherwise constitute a “free writing prospectus,” as defined in Rule 405, required to be filed with the Commission. Any such free writing prospectus consented to by the Agent or by the Company, as the case may be, is hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company represents and warrants that it has treated and agrees that it will treat each Permitted Free Writing Prospectus as an “issuer free writing prospectus,” as defined in Rule 433, and has complied and will comply with the requirements of Rule 433 applicable to any Permitted Free Writing Prospectus, including timely filing with the Commission where required, legending and record keeping. For the purposes of clarity, the parties hereto agree that all free writing prospectuses, if any, listed in Exhibit 21 hereto are Permitted Free Writing Prospectuses.

  • Free Writing Prospectuses; Road Show As of the determination date referenced in Rule 164(h) under the Securities Act, the Company was not, is not or will not be (as applicable) an “ineligible issuer” in connection with the offering of the Offered Shares pursuant to Rules 164, 405 and 433 under the Securities Act. Each free writing prospectus that the Company is required to file pursuant to Rule 433(d) under the Securities Act has been, or will be, filed with the Commission in accordance with the requirements of the Securities Act. Each free writing prospectus that the Company has filed, or is required to file, pursuant to Rule 433(d) under the Securities Act or that was prepared by or on behalf of or used or referred to by the Company complies or will comply in all material respects with the requirements of Rule 433 under the Securities Act, including timely filing with the Commission or retention where required and legending, and each such free writing prospectus, as of its issue date and at all subsequent times through the completion of the public offer and sale of the Offered Shares did not, does not and will not include any information that conflicted, conflicts or will conflict with the information contained in the Registration Statement, the Prospectus or any preliminary prospectus and not superseded or modified. Except for the free writing prospectuses, if any, identified in Schedule B, and electronic road shows, if any, furnished to you before first use, the Company has not prepared, used or referred to, and will not, without your prior written consent, prepare, use or refer to, any free writing prospectus. Each Road Show, when considered together with the Time of Sale Prospectus, did not, as of the Applicable Time, contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.

  • No Free Writing Prospectuses Such Selling Stockholder has not prepared or had prepared on its behalf or used or referred to, any “free writing prospectus” (as defined in Rule 405), and has not distributed any written materials in connection with the offer or sale of the Securities.

  • Offering Communications; Free Writing Prospectuses (a) Unless preceded or accompanied by a prospectus satisfying the requirements of Section 10(a) of the Act, the Underwriter shall not convey or deliver any written communication, as defined in Rule 405 under the Act (a "Written Communication"), to any person in connection with the initial offering of the Certificates, unless such Written Communication (i) is made in reliance on and in conformity with Rule 134 under the Act, (ii) constitutes a prospectus satisfying the requirements of Rule 430B under the Act or (iii) constitutes a "free writing prospectus," as defined in Rule 405 under the Act (a "Free Writing Prospectus"). Notwithstanding anything to the contrary contained in this Agreement, without the prior written consent of WFASC, which may be withheld in its sole discretion, the Underwriter shall not convey or deliver in connection with the initial offering of the Certificates, any Free Writing Prospectus unless such Free Writing Prospectus contains only ABS Informational and Computational Material, as defined in Item 1101(a) of Regulation AB under the Act ("ABS Informational and Computational Material"); provided however, that any such Free Writing Prospectus may also contain a column showing the status of subscriptions for and allotments of the Certificates. The Underwriter shall not convey or deliver any ABS Informational and Computational Material in reliance on Rules 167 and 426 under the Act. Any Free Writing Prospectus prepared by or on behalf of the Underwriter is referred to as an "Underwriter Free Writing Prospectus."

Time is Money Join Law Insider Premium to draft better contracts faster.